Kenneth E Green

Title: Innovations by Kenneth E Green in Retinal Disease Treatment

Introduction

Kenneth E Green is a notable inventor based in Johns Creek, GA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment of retinal diseases. His innovative approach has led to the development of a patented method that addresses critical issues related to retinal degeneration.

Latest Patents

Kenneth E Green holds a patent for "Methods of treating retinal diseases." This patent describes a method of treating or inhibiting degeneration of the retina in subjects in need. The method involves administering an effective amount of metipranolol or its metabolites to the affected organ or tissue. The administration can occur through various routes, including topical, oral, or parenteral methods. Notably, the patent outlines that the dosage may range from 0.5 µg/day to 15 µg/day, depending on the specific needs of the patient.

Career Highlights

Throughout his career, Kenneth E Green has worked with prominent organizations such as Alimera Sciences, Inc. and The Johns Hopkins University. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in retinal health.

Collaborations

Kenneth has collaborated with esteemed colleagues, including Peter Anthony Campochiaro and Yogita Kanan. These partnerships have further enhanced his research and development efforts in treating retinal diseases.

Conclusion

Kenneth E Green's innovative work in the treatment of retinal diseases showcases his dedication to improving patient outcomes. His patented methods represent a significant advancement in ophthalmology, highlighting the importance of continued research and collaboration in the field.